Skip to main content
OpenTrials

Clinical trial condition

HIV Infections

Explore clinical trials studying HIV Infections. Study availability and eligibility vary by location and protocol.

3,971 public trials 134 recruiting studies
Refine in advanced search Browse all conditions

HIV Infections trial results

Active, Not Recruiting

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

NCT02797470

Conditions
Blood-Borne Infections, Burkitt Lymphoma, Communicable Diseases, +41 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV

NCT02016924

Conditions
Acquired Immune Deficiency Syndrome (AIDS), Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Pediatric Infectious Disease Associates Long Beach, California, United States
  • Peter Morton Medical Building Los Angeles, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • The George Washington University Washington D.C., District of Columbia, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)

NCT05996471

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old

NCT04337450

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • King Edward VIII Hospital Durban, South Africa
  • PHRU Klerksdorp Klerksdorp, South Africa
  • PHRU Soweto, South Africa
  • Hospital Universitario 12 de Octubre Madrid, Spain
View all 14 locations
View Trial Details
Active, Not Recruiting

A Clinical Trial to Evaluate the Safety and Immunogenicity of CH505M5 N197D mRNA-gp160 Followed by CH505 TF mRNA-gp160 in Adults in Overall Good Health Without HIV

NCT06557785

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Beth Israel Deaconess Medical Center (Site ID: 32077) Boston, Massachusetts, United States
  • Columbia P&S (Site ID: 30329) New York, United States
  • New York Blood Center (Site ID: 31801) New York, United States
  • Penn Prevention (Site ID: 30310) Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions